Fundraising Fox

Centivax

37 employees on LinkedIn · 4 known investors

Find your way into Centivax

1,731 people in our graph share verified history with the Centivax team — schools, employers, funds. One of them is your warm intro.

Deep Nisharunlockedknows Jacob Glanville · together at Stanford University (overlapped)
×5knows the team · via Stanford University
knows the team · via Cornell
×4knows the team · via University of California, Berkeley
knows the team · via ARCH Venture Partners

Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.

Founders & leadership

JGJacob Glanville
Jacob Glanvillein𝕏Founder, CEO & PresidentJacob Glanville is a computational immunologist and the founder and CEO of Centivax, a biotechnology company developing broad-spectrum vaccines and antibody therapeutics, including a universal influenza vaccine. He previously founded the antibody engineering company Distributed Bio, which was acquired in 2020.
SWStephanie Wisner
Stephanie WisnerinCo-Founder, Treasurer, Chief Business OfficerFounder of Centivax, a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine. She authored a book on biotech entrepreneurship, "Building Backwards to Biotech," aimed at introducing readers to the biotech industry.

Investors · 4

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Centivax went on to found or lead other companies.

Competitors · 2

by search overlap

Companies competing with Centivax for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Centivax do?
Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.
Who founded Centivax?
Centivax was founded by Jacob Glanville, Stephanie Wisner.
Who are Centivax's investors?
Centivax's investors include Amplify Partners, Bold Capital Partners, Future Ventures, NFX.